BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2697443)

  • 21. Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation.
    Casorati G; Locatelli F; Pagani S; Garavaglia C; Montini E; Lisini D; Turin I; Rossi F; Dellabona P; Maccario R; Montagna D
    Exp Hematol; 2005 Feb; 33(2):212-8. PubMed ID: 15676215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is marrow purging necessary or clinically useful?
    Keating A
    Bone Marrow Transplant; 1991; 7 Suppl 1():61-5. PubMed ID: 2043890
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro purging of bone marrow for autologous marrow transplantation in acute myelogenous leukemia using myeloid-specific monoclonal antibodies.
    Ball ED
    Bone Marrow Transplant; 1988 Sep; 3(5):387-92. PubMed ID: 3056546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of bone marrow cell dose in bone marrow transplantation.
    Paulin T
    Clin Transplant; 1992 Feb; 6(1):48-54. PubMed ID: 10150090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of autologous bone marrow transplantation for patients with acute and chronic leukemias.
    Geller RB
    Hematol Oncol Clin North Am; 1993 Jun; 7(3):547-75. PubMed ID: 8344882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autologous bone marrow transplantation for leukemia.
    Stuart RK
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):40-54. PubMed ID: 8211215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Monoclonal antibody and purging].
    Ueda R; Morishima Y
    Gan No Rinsho; 1989 May; Spec No():294-302. PubMed ID: 2601016
    [No Abstract]   [Full Text] [Related]  

  • 28. [Allogenic bone marrow transplantation in acute leukemias and chronic myeloid leukemia].
    Mendeleeva LP
    Ter Arkh; 2003; 75(7):89-94. PubMed ID: 12934492
    [No Abstract]   [Full Text] [Related]  

  • 29. Autologous bone marrow transplantation after in vitro purging with monoclonal antibodies and complement in acute lymphoblastic leukemia.
    Perez-Oteyza J; Larana JG; Brieva J; Roldan E; Odriozola J; Maldonado M; Otheo E; Munoz A; Bootello A; Navarro JL
    Prog Clin Biol Res; 1992; 377():163-8. PubMed ID: 1438412
    [No Abstract]   [Full Text] [Related]  

  • 30. Hyperferritinaemia in children undergoing bone marrow transplantation.
    Rajantie J
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():92. PubMed ID: 2627613
    [No Abstract]   [Full Text] [Related]  

  • 31. Bone marrow transplantation. The state of the art.
    Thomas ED
    Ann Ital Med Int; 1986 Jun; 1(2):109-14. PubMed ID: 3079358
    [No Abstract]   [Full Text] [Related]  

  • 32. Bone marrow transplantation in hematologic malignancies. Current status.
    Santos GW
    Cancer; 1990 Feb; 65(3 Suppl):786-91. PubMed ID: 2406002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful engraftment after autologous transplantation of 10-day cultured bone marrow activated by interleukin 2 in patients with acute lymphoblastic leukemia.
    Beaujean F; Bernaudin F; Kuentz M; Lemerle S; Cordonnier C; Le Forestier C; Reinert P; Duedari N; Brandely M; Vernant JP
    Bone Marrow Transplant; 1995 May; 15(5):691-6. PubMed ID: 7670397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow transplantation for acute leukemia: a preliminary report from the International Bone Marrow Transplant Registry.
    Champlin R
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2626-8. PubMed ID: 3274570
    [No Abstract]   [Full Text] [Related]  

  • 35. Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide (BuCy2).
    Copelan EA; Biggs JC; Szer J; Thompson JM; Crilley P; Brodsky I; Klein JL; Kapoor N; Harman GS; Avalos BR
    Semin Oncol; 1993 Aug; 20(4 Suppl 4):33-8; quiz 39. PubMed ID: 8342074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bone marrow transplantation in the treatment of acute leukemias].
    Moiseev SI; Ganapiev AA; Abdulkadyrov KM
    Ter Arkh; 1996; 68(12):8-10. PubMed ID: 9054052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapeutic advances in bone marrow transplantation].
    Brenner MK; Grob JP; Prentice HG
    Clin Ter; 1987 Sep; 122(5):321-32. PubMed ID: 2972448
    [No Abstract]   [Full Text] [Related]  

  • 38. Natural killer cell regeneration after transplantation with mafosfamide purged autologous bone marrow.
    Almici C; Manoni L; Carlo-Stella C; Garau D; Cottafavi L; Rizzoli V
    Bone Marrow Transplant; 1995 Jul; 16(1):95-101. PubMed ID: 7581136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autologous BMT in high risk patients with CALLA-positive ALL: possible efficacy of ex vivo marrow leukemia cell purging with monoclonal antibodies and complement.
    Morishima Y; Miyamura K; Kojima S; Ueda R; Morishita Y; Sao H; Tanimoto M; Ohno R; Sobue R; Hirano M
    Bone Marrow Transplant; 1993 Apr; 11(4):255-9. PubMed ID: 7683550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous bone marrow transplantation for acute lymphoblastic leukemia: role of bone marrow purging.
    Canals C; Picón M; Sanchez T; Torrico C; Amill B; Tugues D; Sierra J; Grañena A; Badell I; Brunet S
    Prog Clin Biol Res; 1994; 389():125-32. PubMed ID: 7700894
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.